Peripheral blood stem cells for autografting

Annual Review of Medicine

Volumn 48, Issue , 1997, Pages 241-251

  Shpall, Elizabeth J ^a   Cagnoni, Pablo J ^a   Bearman, Scott I ^a   Ross, Maureen ^a   Jones, Roy B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Autotransplants; Bone marrow; Peripheral blood progenitor cells

Indexed keywords

GROWTH FACTOR;

AUTOGRAFT; BONE MARROW; COST EFFECTIVENESS ANALYSIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVIEW; SAFETY; STEM CELL TRANSPLANTATION; TUMOR CELL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW PURGING; COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0031058274     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.48.1.241     Document Type: Review

References (58)

1. Kessinger A, Armitage JO, Landmark JD, et al. 1988. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 71:723-27
2. Juttner CA, To LB, Ho JQ, et al. 1988. Early lymphohematopoietic recovery after autografting using peripheral blood stem cells in acute nonlymphoblastic leukemia. Transplant Proc. 20:40-42
3. Sheridan W, Begley CG, Juttner CA, et al. 1992. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1:640-44
4. Peters WP, Davis R, Shpall EJ, et al. 1990. Adjuvant chemotherapy involving high-dose combination CPA/BCNU/cDDP with bone marrow support for stage II/II breast cancer involving ten or more lymph nodes (CALGB 8782): a preliminary report. Proc. Am. Soc. Clin. Oncol. 31:22
5. Gianni AM, Bregni M, Siena S, et al. 1989. Rapid and complete hematopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high-dose chemoradiotherapy? Hematol. Oncol. 7: 139-43
6. Juttner CA, To LB, Roberts MM, et al. 1992. Comparison of hematologic recovery, toxicity, and supportive care of autologous PBSC, autologous BM, and allogeneic BM transplants. Int. J. Cell Cloning 10:160
7. Reiffers J, Castaigne S, Tilly H, et al. 1987. Hematopoietic reconstitution after autologous blood stem cell transplantation: a report of 46 cases. Plasma Ther. Transfus. Technol. 8:360-64
8. Stiff PJ, Murgo AJ, Wittes RE, et al. 1983. Quantification of peripheral blood colony forming unit-culture rise following chemotherapy: Could leukocytaphereses replace bone marrow for autologous transplantation? Transfusion 23:500-3
9. Juttner C, To LB. 1991. Peripheral blood stem cells: mobilization by myelosuppressive chemotherapy. In Proc. 5th Int. Symp. Autologous Bone Marrow Transplant, pp. 783-88. Omaha: Univ. Nebr. Press
10. Reiffers J, Faberes C, Commenges D, et al. 1991. The CD34 assay is not of predictive value for engraftment after PBSC transplantation. In Proc. 2nd Int. Symp. Peripheral Blood Stem Cell Autografts, Mulhouse, France
11. Sienna S, Bregni M, Brando B, et al. 1991. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400-6
12. Bensinger WI, Longin K, Appelbaum F, et al. 1994. Peripheral blood stem cells collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87:825-31
13. Kessinger A, Armitage JO. 1991. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77:211-13
14. Williams SF, Bitran JD, Richards JM, et al. 1990. Peripheral blood-derived stem cell collections for use in autologous transplantation after high-dose chemotherapy: an alternative approach. Bone Marrow Transplant. 5:129-33
15. Cantin G, Marchand-Laroche D, Bouchard MM, Leblond PF. 1989. Blood-derived stem cell collection in acute nonlymphoblastic leukemia: predictive factors for a good yield. Exp. Hematol. 17: 991
16. To LB, Shepperd KM, Haylock DN, et al. 1990. Single high doses of cyclophosphamide enable the collection of high numbers of stem cells from the peripheral blood. Exp. Hematol. 18:442
17. Kessinger A, Armitage JO, Smith DM, et al. 1989. High-dose therapy and autologous marrow peripheral blood stem cell transplantation for patients with lymphoma. Blood 74:1260
18. Shpall EJ, Jones RB, Bearman SI, et al. 1994. Transplantation of CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28-36
19. Elias A, Mazanet R, Anderson K, et al. 1991. GM-CSF mobilized stem cell autografts. In Proc. 2nd Int. Symp. Peripheral Blood Stem Cell Autografis, Mulhouse, France
20. Gianni AM, Siena S, Bregni M, et al. 1989. Granulocyte-macrophage colony stimulating factor to harvest circulating hematopoietic stem cells for autotransplantation. Lancet 2:580-86
21. Haas R, Ho AD, Bredthauer U, et al. 1990. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony stimulating factor. Exp. Hematol. 18: 94
22. Vose JM, Kessinger A, Bierman P, et al. 1991. The use of rh-IL-3 for mobilization of peripheral blood stem cells in previously treated patients with lymphoid malignancies. In Proc. 2nd Int. Symp. Peripheral Blood Stem Cell Autografts, Mulhouse, France
23. Duhrsen U, Villeval JL, Boyd J, et al. 1988. Effects of recombinant granulocyte colony stimulating factor on hematopoietic progenitor cells in cancer patient. Blood 72: 2074-81
24. Socinski MA, Cannistra SA, Elias A, et al. 1988. Granulocyte-macrophage colony stimulating factor expands the circulating hematopoietic progenitor cell compartment in man. Lancet 1:1194-98
25. McNiece I, Langley KE, Zsebo KM. 1992. Recombinant SCF synergizes with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hematol. 19:226-31
26. Hara H, Namiki M. 1989. Mechanism of synergy between GM-CSF and G-CSF in colony formation from human marrow cells in vitro. Exp. Hematol. 17:816-21
27. Brucher J, Martin H, Hess U. et al. 1991. Interleukin-3 combined with rGM-CSF efficiently mobilizes circulating hematopoietic progenitor cells without prior chemotherapy. In Proc. 2nd Int. Symp. Peripheral Blood Stem Cell Autografts, Mulhouse, France
28. Spitzer G, Huan SD, Hester J, et al. 1991. Influence of mobilized peripheral blood cells on the hematopoietic recovery from autologous marrow and recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) following high-dose cyclophosphamide, etoposide, and cisplatin. In Proc. 2nd Int. Symp. Peripheral Blood Stem Cell Autografts, Mulhouse, France
29. Zsebo K, Williams D, Geissler EN, et al. 1990. Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213-19
30. Andrews RG, Bartelmez SH, Knitter GH, et al. 1992. A c-kit ligand, recombinant human stem cell factor mediates reversible expansion of CD34+ colony-forming cells types in blood and marrow of baboons. Blood 80:920-25
31. Briddell RA, Hartley CA, Smith KA, McNiece IK. 1993. Recombinant rat SCF synergizes with recombinant human G-CSF in vivo to mobilize PBPCs which have enhanced repopulating potential. Blood 82: 1720-23
32. Andrews RG, Appelbaum FR, Bensinger WI, et al. 1992. Stem cell factor stimulates the in vivo expansion of hematopoietic progenitor cells and stimulates circulation of cells that engraft and rescue lethally irradiated recipients. In Proc. 6th Int. Symp. Autologous Bone Marrow Transplant., Houston, Texas
33. Crawford J, Lau D, Erwin R, et al. 1993. A phase I trial of recombinant methionyl human stem cell factor (SCF) with advanced non-small cell lung carcinoma. Proc. Am. Soc. Clin. Oncol. 12:135
34. Demetri G, Costa J, Hayes D, et al. 1993. A phase I trial of recombinant methionyl human stem cell factor in patients with advanced breast cancer pre and post chemotherapy with cyclophosphamide and doxorubicin. Proc. Am. Soc. Clin. Oncol. 12:1425
35. Glaspy J, McNiece I, LeMaistre F, et al. 1994. Effects of stem cell factor (rhSCF) and filgrastim (rhG-CSF) on mobilization of peripheral blood progenitor cells (PBPC) and on hematological recovery posttransplant: early results from a phase I/II study. Proc. Am. Soc. Clin. Oncol. 13: 68
36. Sharp JG, Armitage J, Grouse D, et al. 1989. Are occult tumor cells present in peripheral stem cell harvests of candidates forautologous transplantation? In Proc. 4th Int. Symp. Autologous Transplant, pp. 693-703. Houston: MD Anderson Press
37. Negrin RS, Kiem HP, Schmidt-Wolf IGH, et al. 1991. Use of polymerase chain reaction to monitor effectiveness of ex vivo tumor cell purging. Blood 77:654-60
38. Sharp J, Kessinger A, Mann S, et al. 1992. Detection and clinical significance of minimal tumor cell contamination of peripheral blood stem cell harvests. Int. J. Cell Cloning 10:92-94
39. Osborne MP, Wong GY, Gonzalez A, et al. 1993. Bone marrow micrometastases (BMM) in breast cancer: the effect of tumor cell (TC) burden on early relapse. Proc. Am. Soc. Clin. Oncol. 12:75
40. Ross AA, Cooper BW, Lazarus H, et al. 1993. Incidence of tumor cell contamination in peripheral blood stem cell (PBSC) collections from breast cancer patients. Proc. Am. Soc. Clin. Oncol. 12:68
41. Shpall EJ, Jones RB. 1994. Release of tumor cells from bone marrow. Blood 83: 623-25
42. Brugger W, Bross KJ, Glatt M, et al. 1994. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636-40
43. Vredenburgh J, Silva O, de Sombre K, et al. 1995. The significance of bone marrow micrometastases for patients with breast cancer and 10+ nodes treated with high-dose chemotherapy and hematopoietic support. Proc. Am. Soc. Clin. Oncol. 14:317
44. Gribben J, Freedman A, Neuberg D, et al. 1991. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 325:1525-33
45. Rill DR, Santana VM, Roberts WM, et al. 1994. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-83
46. Andrews RG, Singer JW, Bernstein ID. 1986. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842-45
47. Berenson R, Bensinger W, Kalamasz D. 1986. Positive selection of viable cell populations using avidin-biotin immunoadsorption. J. Immun. Methods 91:11-19
48. Franklin WA, Shpall EJ, Archer P, et al. 1996. Immunohistochemical detection and quantiution of metastatic breast cancer in human bone marrow and peripheral blood. Breast Cancer Res. Treat. In press
49. Cagnoni PJ, Jones RB, Franklin W, et al. 1995. Use of CD34-positive autologous hematopoietic progenitors to support patients with breast cancer after high-dose chemotherapy. Blood 86:386a
50. Chang J, Morgenstern GR, Coutinho LH, et al. 1989. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukemia: an update. Bone Marrow Transplant 4:5-9
51. Haylock DN, To LB, Dowse CA, et al. 1992. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 80:1405-12
52. Purdy MH, Hogan CJ, Hami L, et al. 1995. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. J. Hematother. 4:515-25
53. Barnett MJ, Eaves CJ, Philips GL, et al. 1994. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood 84:724-32
54. Dexter TM, Chang J. 1994. New strategies for the treatment of chronic myelogenous leukemia. Blood 84:673-75
55. Smith C. 1992. Retroviral vector-mediated gene transfer into hematopoietic cells: prospects and issues. J. Hematother. 1: 155-66
56. Bregni M, Magni M, Siena S, et al. 1992. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 80:1418-22
57. Nolta JA, Crooks GM, Overell RW, et al. 1992. Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: effect of mast cell growth factor (MGF) combined with other cytokines. Exp. Hematol. 20:1065-71
58. Brugger W, Scheding S, Heimfeld S, et al. 1994. Ex vivo expanded peripheral blood CD34+ cells mediate hematopoietic recovery in cancer patients after high-dose VP16, ifosfamide, carboplatin and epirubicin. Blood 84:395a